Drug Database
Back to search

Germany· DE-A57-e8b54986b5ad7b54

Efavirenz/Emtricitabin/Tenofovirdisoproxil Ratiopharm

A medicinal product containing emtricitabine, efavirenz, tenofovir disoproxil phosphate, registered in Germany by Ratiopharm Gmbh.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedEfavirenz/Emtricitabin/Tenofovirdisop…ATC—REGISTER NO.DE-A57-e8b54986b5ad7b…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about emtricitabine, efavirenz, tenofovir disoproxil phosphateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

EMA Article 57 (European Union)
Active substance
Emtricitabine, Efavirenz, Tenofovir Disoproxil Phosphate
Manufacturer
Ratiopharm Gmbh
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine, efavirenz, tenofovir disoproxil phosphate in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, efavirenz, tenofovir disoproxil phosphate products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Efavirenz/Emtricitabin/Tenofovirdisoproxil Ratiopharm
  • Denmark · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
  • Estonia · Efavirenz/Emtricitabine/Tenofovir Disoproxil Zentiva K.S., Padviram
  • Spain · Efavirenz/Emtricitabina/Tenofovir Disoproxilo Aurovitas, Efavirenz/Emtricitabina/Tenofovir Disoproxilo Dr. Reddys
  • Finland · Fatrino
  • France · Efavirenz/Emtricitabine/Tenofovir Disoproxil Arrow, Efavirenz/Emtricitabine/Tenofovir Disoproxil Bgr
  • United Kingdom (Northern Ireland) · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark Pharmaceuticals Europe, Efavirenz/Emtricitabine/Tenofovir Disoproxil Macleods
  • Croatia · Efavirenz/Emtricitabin/Tenofovirdizoproksil Stada
  • Ireland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
  • Iceland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
  • Italy · Efavirenz E Emtricitabina E Tenofovir Disoproxil Aurobindo, Efavirenz/Emtricitabina/Tenofovir Disoproxil Zentiva K.S.
  • Liechtenstein · Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 Mg/200 Mg/245 Mg Film-Coated Tablets Mylan
  • Netherlands · Efavirenz/ Emtricitabine/ Tenofovir Disoproxyl Fumarate Aurobindo, Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark
  • Norway · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
  • Poland · Efavirenz + Emtricitabine + Tenofovir Disoproxil Aurovitas
  • Portugal · Efavirenz + Emtricitabina + Tenofovir Generis, Efavirenz + Emtricitabina + Tenofovir Teva
  • Romania · Efavirenz/Emtricitabină/Tenofovir Disoproxil Zentiva K.S.
  • Sweden · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e8279c03-7907-42cd-b394-332162f67bbc
GET /v1/drugs/e8279c03-7907-42cd-b394-332162f67bbc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Emtricitabine, Efavirenz, Tenofovir Disoproxil Phosphate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about emtricitabine, efavirenz, tenofovir disoproxil phosphate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console